{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Antipsychotics&page=12", "query": { "intervention": "Antipsychotics", "page": 12 }, "page_size": 10 }, "pagination": { "page": 12, "page_size": 10, "total_count": 380, "total_pages": 38, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Antipsychotics&page=13&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Antipsychotics&page=11&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-26T17:28:36.119Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01994109", "title": "Efficacy and Safety Study of MYOBLOC® in the Treatment of Sialorrhea in Adult Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Sialorrhea" ], "interventions": [ { "name": "MYOBLOC", "type": "DRUG" }, { "name": "PLACEBO", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 187, "start_date": "2013-11", "completion_date": "2017-01", "has_results": true, "last_update_posted_date": "2026-04-21", "last_synced_at": "2026-10-26T17:28:36.119Z", "location_count": 24, "location_summary": "Loma Linda, California • Los Angeles, California • National City, California + 21 more", "locations": [ { "city": "Loma Linda", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "National City", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01994109" }, { "nct_id": "NCT00255879", "title": "Movement Disorders Caused by Antipsychotic Drugs in Older Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Dyskinesia, Drug-Induced" ], "interventions": [ { "name": "Quetiapine", "type": "DRUG" }, { "name": "Risperidone", "type": "DRUG" }, { "name": "Olanzapine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Diego", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 250, "start_date": "1999-01", "completion_date": "2004-08", "has_results": false, "last_update_posted_date": "2013-06-06", "last_synced_at": "2026-10-26T17:28:36.119Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00255879" }, { "nct_id": "NCT03565068", "title": "A Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and in Healthy Participants (MK-8189-007)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "MK-8189", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Background AAP Therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 75, "start_date": "2018-06-20", "completion_date": "2020-04-03", "has_results": true, "last_update_posted_date": "2021-03-29", "last_synced_at": "2026-10-26T17:28:36.119Z", "location_count": 1, "location_summary": "Glendale, California", "locations": [ { "city": "Glendale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03565068" }, { "nct_id": "NCT01192880", "title": "A Study to Evaluate Efficacy and Safety of Bitopertin in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Bitopertin", "type": "DRUG" }, { "name": "Antipsychotics", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 625, "start_date": "2010-11", "completion_date": "2014-07", "has_results": false, "last_update_posted_date": "2017-02-15", "last_synced_at": "2026-10-26T17:28:36.119Z", "location_count": 27, "location_summary": "Costa Mesa, California • Escondido, California • Granada Hills, California + 24 more", "locations": [ { "city": "Costa Mesa", "state": "California" }, { "city": "Escondido", "state": "California" }, { "city": "Granada Hills", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01192880" }, { "nct_id": "NCT01235559", "title": "A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "bitopertin [RO4917838] level 1", "type": "DRUG" }, { "name": "bitopertin [RO4917838] level 2", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 604, "start_date": "2010-12", "completion_date": "2015-03", "has_results": false, "last_update_posted_date": "2016-11-02", "last_synced_at": "2026-10-26T17:28:36.119Z", "location_count": 22, "location_summary": "Costa Mesa, California • Escondido, California • Granada Hills, California + 19 more", "locations": [ { "city": "Costa Mesa", "state": "California" }, { "city": "Escondido", "state": "California" }, { "city": "Granada Hills", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01235559" }, { "nct_id": "NCT00347425", "title": "Switch Study of Existing Atypical Antipsychotics to Bifeprunox", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia and Schizoaffective Disorder" ], "interventions": [ { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Olanzapine", "type": "DRUG" }, { "name": "Risperidone", "type": "DRUG" }, { "name": "Quetiapine", "type": "DRUG" }, { "name": "Ziprasidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Solvay Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 286, "start_date": "2006-12", "completion_date": "2008-02", "has_results": false, "last_update_posted_date": "2008-05-21", "last_synced_at": "2026-10-26T17:28:36.119Z", "location_count": 63, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Anaheim, California + 54 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Cerritos", "state": "California" }, { "city": "Cerritos", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00347425" }, { "nct_id": "NCT00937716", "title": "Treatment Response in Schizophrenia: Bridging Imaging and Postmortem Studies", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Schizophrenia" ], "interventions": [], "intervention_types": [], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "19 Years to 55 Years" }, "enrollment_count": 75, "start_date": "2008-10", "completion_date": "2021-06-30", "has_results": false, "last_update_posted_date": "2021-07-26", "last_synced_at": "2026-10-26T17:28:36.119Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00937716" }, { "nct_id": "NCT01129674", "title": "A Long-Term, Open-Label, Study on Schizophrenia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "LY2140023", "type": "DRUG" }, { "name": "Olanzapine", "type": "DRUG" }, { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Risperidone", "type": "DRUG" }, { "name": "Quetiapine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Denovo Biopharma LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 560, "start_date": "2010-06", "completion_date": "2012-10", "has_results": false, "last_update_posted_date": "2026-09-14", "last_synced_at": "2026-10-26T17:28:36.119Z", "location_count": 42, "location_summary": "Little Rock, Arkansas • Escondido, California • Garden Grove, California + 39 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Escondido", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "National City", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01129674" }, { "nct_id": "NCT00065286", "title": "Akathisia (Restless Legs Syndrome) in People With Schizophrenia and Mental Retardation", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Akathisia" ], "interventions": [], "intervention_types": [], "sponsor": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": null, "start_date": "1996-12", "completion_date": "1999-11", "has_results": false, "last_update_posted_date": "2005-06-24", "last_synced_at": "2026-10-26T17:28:36.119Z", "location_count": 2, "location_summary": "Morganton, North Carolina • University Park, Pennsylvania", "locations": [ { "city": "Morganton", "state": "North Carolina" }, { "city": "University Park", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00065286" }, { "nct_id": "NCT00183625", "title": "Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Individual Placement and Support (Supported Employment)", "type": "BEHAVIORAL" }, { "name": "Social Skills Training", "type": "BEHAVIORAL" }, { "name": "Olanzapine", "type": "DRUG" }, { "name": "Risperidone", "type": "DRUG" } ], "intervention_types": [ "BEHAVIORAL", "DRUG" ], "sponsor": "University of California, Los Angeles", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 107, "start_date": "2000-06", "completion_date": "2006-09", "has_results": true, "last_update_posted_date": "2026-02-09", "last_synced_at": "2026-10-26T17:28:36.119Z", "location_count": 2, "location_summary": "Los Angeles, California • Manchester, New Hampshire", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Manchester", "state": "New Hampshire" } ], "official_url": "https://clinicaltrials.gov/study/NCT00183625" } ] }